Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Vista Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 11.24 -0.59  | -4.99% -67.13% 36.78 34.13
BSE Price: Sep 17, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Sep 17, 2019 11.24 -0.59 -4.99% 12.39 11.83 9,250 11.24 - 12.39
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 25,022 P/B: 1.02 NSE Code:
52-Week Range: R 7.00 - 34.35 Dividend Yield: 0.00% BSE Code: 524711
TTM EPS: R 0.31 Book Value: R 11.00 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Procter & Gamble Health (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 37 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Vista Pharmaceuticals -61.24 28.46 -25.32 -67.13 -18.66 -4.81 1.63
S&P BSE Small Cap -12.59 2.15 -9.29 -22.85 0.24 3.49 5.79
S&P BSE Healthcare -7.73 2.98 0.80 -20.01 -7.95 -1.28 12.40
Company's return has been calculated on basis of BSE's price.
As on Sep 17, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 7.45 26.42 30.21
Net Profit -57.04 6.66 15.01
EPS -58.76 -0.04 -0.12
Book Value 21.66 34.76 12.60
Average
Operating Margin 13.47 15.39 16.60
Net Margin 2.76 5.12 6.06
Return on Networth 3.15 7.44 8.68
Return on Investment 6.28 9.21 10.27
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -41.53 18.78 -41.53
Operating Profit -8.01 -27.26 -8.01
Net Profit -85.60 -10.48 -85.60
EPS -85.59 -13.89 -85.59
TTM
Revenue 3.62 19.61 3.62
Operating Profit -7.50 -31.81 -7.50
Net Profit -1.17 -50.93 -1.17
EPS -1.60 -53.14 -1.60
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Vista Pharmaceuticals 34.13 32.20 0.93 2.46 3.15 1.02 36.78
Eris Lifesciences 5,605.31 1,005.70 303.64 29.29 28.96 4.54 18.46
Procter & Gamble Health 7,095.90 895.21 852.46 14.77 73.79 9.54 50.91
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Feb 06, 2019 Vasant V Alli  Buy Conv. of Warrants 190,574 23.95 45.64
Feb 06, 2019 Vasant V Alli  Sell Conv. of Warrants 190,574 23.95 45.64
Jan 24, 2019 Vasant V Alli  Buy Conv. of Warrants 189,851 27.20 51.64
Jan 24, 2019 Vasant V Alli  Sell Conv. of Warrants 189,851 27.20 51.64
Dec 26, 2018 Vasant V Alli  Sell Preferential Allotment 837,720 27.45 229.95
Review & Analysis
News & Announcements
Contact Information

Company: Vista Pharmaceuticals Ltd.

Address: Plot Nos. 10 To 14 And 16 To 20, T S I I C Industrial Estate, Chityal, Gopalaipalli Village, Narketpally Mandal, Nalgonda Dist, Telangana - 508205 | Phone: 09291015956 | Fax: 08682-272551

Email: [email protected]

Website: www.vistapharmaceuticals.com

Registrar & Transfer Agent: Aarthi Consultants Pvt Ltd

Address: 1-2-285 , Domalaguda,,Hyderabad, 1-2-285, Domalaguda | Phone: 040-7642217/7634445 | Fax: 040-7632184

Essential checks
Altman Z-Score
2.98
Piotroski F-Score
5
Modified C-Score
3
3-Years Price to Earnings
36.78
3-Years Price to Book
1.02
Earnings Yield
EBIT / Enterprise value
5.66%
PEG
Price / Earnings to growth ratio
0.91
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,010.60 -5.21%
Caplin Point Laboratories R423.50 -0.77%
Eris Lifesciences R407.65 -3.64%
FDC R169.55 -3.31%
JB Chemicals & Pharma R392.10 -0.67%
Laurus Labs R341.20 +0.04%
Procter & Gamble Health R4,269.75 -3.65%
Strides Pharma Science R366.15 -3.71%
Sun Pharma Adv. Research R160.75 -3.51%
Suven Life Sciences R284.20 -3.48%
As on Sep 17, 15:59